Pappas Ventures 1

Pappas Ventures II

Founded in 1994, Pappas Capital is a global venture capital and commercial development firm that specializes in investments in next-generation life science, agriculture, and technology companies across the United States and Canada, with select investments in Asia and Europe.

Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.



Cyclerion Therapeutics

VelosBio

Milestone Pharmaceuticals

Mirum Pharmaceuticals

Reneo Pharmaceuticals

BioAtla

4D Molecular Therapeutics

Amplyx Pharmaceuticals

Athersys

Pappas Capital

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

Google Maps

WordPress

LetsEncrypt

Global Site Tag

Art Pappas

Venture Partner

Barry Myers

Chief Financial Officer

Matthew Boyer

Principal

Bert Kinsey

Healthcare

Drew Cutshaw

Director Accounting - Operations Harland Clarke

Elaine Staedeli

Managing Director

Elizabeth Kelly

Analyst and Business Development Manager

Brian Gibbs

Office Manager

Carolyn Cooke

Business Management

Lee Babiss

Ford Worthy

Lisa Dreyer

Senior Associate, Operations

Karen LeVert

Mankit Law

Artthur M. Pappas

Cookie Yu

Associate

Managing General Partner

Partner & Senior Advisor

BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates  to treat haematological cancers.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.

Venture Capital Investors with Investments in Maryland

Venture Capital Investors with Investments in West Coast

Late Stage Venture Investors with Investments in Silicon Valley

Investors Active in La Jolla, California

Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas Ventures, their flagship venture arm; Specialized Fund Management, where we create and manage custom-tailored investment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.

A. M. Pappas Life Science Ventures V

Durham

North Carolina

United States

North America

Why Pappas Capital is putting money into a Singapore startup

India

Asia

United Kingdom

Europe

Bangladesh

Pakistan

Hatteras Venture Partners is a venture capital firm that invests in early-stage life science companies.

Hatteras Venture Partners

SJF Ventures is a venture capital firm that focuses on high-growth, positive-impact companies in the resource efficiency, sustainability, and technology-enhanced services sectors.

SJF Ventures

Abingworth is a leading international investment group dedicated to investing in life sciences.

Abingworth

Seroba Life Sciences is a venture capital firm that invests in innovative therapeutic and diagnostic medical devices and biopharmaceuticals.

Seroba Life Sciences

Pappas Capital is a global venture capital and commercial development firm focused on advancing life science, agriculture, and technology companies. It operates through three main business lines: Pappas Ventures, which is the firm's flagship life science venture arm; Specialized Fund Management, which creates and manages custom-tailored investment vehicles; and Translational Medicine, which partners with research universities to expedite the development of scientific discoveries and inventions.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 1, 2024 11:29 AM	b8bfaca4
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 1, 2024 1:01 PM	8d57645b
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	7b3f4b42
crunchbase profile	general	Nov 4, 2024 11:28 AM	f51ce82e
li profile	general	Jul 1, 2024 11:29 AM	f30998e0
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	06a7c0e5
peers	general
news basic	general	Jul 1, 2024 11:29 AM	8bd44674
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PAPPAS-CAPITAL

Pappas Capital